For many people, controlling high blood pressure is not easy. Even after taking several medications, their blood pressure remains high. This condition is known as resistant hypertension, and it increases the risk of serious health problems such as heart attacks, strokes, and kidney disease.
A new study from University College London has found a potential solution. Researchers have tested a new drug called baxdrostat, which appears to lower blood pressure in people who have not responded well to other treatments.
The study involved almost 800 patients from clinics around the world. These patients were already taking multiple blood pressure medications but still had high readings. This makes them a particularly difficult group to treat.
Participants in the study were given either baxdrostat or a placebo for 12 weeks. The results showed that those taking the new drug had a much greater reduction in blood pressure. On average, their systolic blood pressure dropped by about 9 to 10 mmHg more than those taking the placebo.
This difference may seem small, but it is very important. Even a modest drop in blood pressure can significantly reduce the risk of major health events. The study also found that around 40 percent of patients taking baxdrostat reached normal blood pressure levels, compared to less than 20 percent in the placebo group.
The research was led by Professor Bryan Williams and presented at a major heart conference in Europe. It was also published in the New England Journal of Medicine, showing the importance of the findings.
The key to this drug’s success lies in how it works. Baxdrostat targets a hormone called aldosterone. This hormone controls how the body handles salt and water. When too much aldosterone is produced, the body holds onto extra fluid, which raises blood pressure.
By blocking this hormone, baxdrostat helps reduce fluid buildup and lowers blood pressure. This approach is different from many existing treatments, which may not address this specific cause.
The study also showed that the drug continued to work over time. Patients maintained lower blood pressure levels for many months, and there were no unexpected safety issues during the trial.
High blood pressure is a growing global problem. Today, it affects people in all parts of the world, especially in Asia and developing countries. Many patients do not reach their target blood pressure levels, even with treatment.
This new drug could change how doctors treat these patients. It provides a new option for those who have not benefited from current medications.
However, more research is needed before the drug becomes widely available. Long-term safety, cost, and access will all need to be considered.
Still, the results are encouraging. They suggest that targeting the underlying causes of high blood pressure may be more effective than simply adding more medications.
If you care about blood pressure, please read studies about blood pressure drug that may increase risk of sudden cardiac arrest, and these teas could help reduce high blood pressure.
For more health information, please see recent studies about nutrient that could strongly lower high blood pressure, and results showing this novel antioxidant may help reverse blood vessels aging by 20 years.
Source: University College London.
